darmstadt germany news from FierceBiotech
News
Struengmanns to invest in German biotech firms
Twin brothers Thomas and Andreas Struengmann made a fortune selling their generic drug business back in 2005. Now they plan to invest a good bit of their money in Germany's biotech industry. In an Read more...
Novartis, MorphoSys ink $1B antibody deal
There's fresh evidence this morning that antibodies remain one of the hottest commodities in biotechnology. Novartis has extended its antibody development deal with Germany's MorphoSys, agreeing to Read more...
ALSO NOTED: Ventana and Roche forge confidentiality agreement; Rigel wins $3M payment; and much more...
> Ventana Medical Systems and Roche have made nice over a confidentiality agreement, raising the prospects of a takeover. One analyst says that Ventana would likely fetch more than $87 a share. Read more...
Antisense Pharma lands $38M in VC
Germany's Antisense Pharma has landed €27 million ($38 million) from the VC-funds of MIG Fonds, a fund initiator of closed-end venture capital funds that raises capital for and invests in Read more...
GPC shares crater on Phase III cancer failure
Germany's GPC Biotech saw its already battered stock price crater this morning after announcing that its experimental prostate cancer drug, satraplatin, failed to help patients live longer in a Read more...
Direvo pockets $17M in investment round
Germany's Direvo Biotech, a protein engineering company, has raised $16.8 million in its third round. Part of that money is being earmarked for its collaboration and research programs in therapeutic Read more...
Evotec adds drugs in Renovis buyout
Germany's Evotec is boosting its pipeline to five compounds with the acquisition of Renovis for $152 million in an all-stock transaction. An insomnia drug is slated to begin a human clinical trial by Read more...
Nabi sells unit for $185M, plans Maryland move
Nabi Biopharmaceuticals plans to sell its biologics unit to Germany's Biotest for $185 million. Biotest gains a headquarters facility in Boca Raton, a plasma protein plant, Nabi-HB Hepatitis B immune Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets